WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

BACKGROUND: Cutaneous leishmaniasis (CL) is a disfiguring disease that confronts clinicians with a quandary: leave patients untreated or engage in a complex or toxic treatment. Topical treatment of CL offers a practical and safe option. Accordingly, the treatment of CL with WR279,396, a formulation...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ben Salah, Afif, Buffet, Pierre A., Morizot, Gloria, Ben Massoud, Nathalie, Zâatour, Amor, Ben Alaya, Nissaf, Haj Hamida, Nabil Bel, Ahmadi, Zaher El, Downs, Matthew T., Smith, Philip L., Dellagi, Koussay, Grögl, Max
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2009
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2673687/
https://ncbi.nlm.nih.gov/pubmed/19415122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000432
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky